AVIR Atea Pharmaceuticals, Inc.

5.010USD-1.18%Mkt Cap: 401.83M $P/E: —

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the re…

Key Statistics

Company
Market Cap401.83M USD
Enterprise Value187.60M USD
Revenue (TTM)—
Gross Profit-155.12M USD
Net Income (TTM)-158.35M USD
Revenue/Share—
Last Price5.010 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.43
PEG—
EV/EBITDA-1.03
EV/Revenue—
P/S—
P/B1.99
EPS (TTM)-2.09
EPS (Forward)-1.48
52W Range
2.78061% of range6.450
52W High6.450 USD
52W Low2.780 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.49%
ROA-50.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-132.03M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-23.10%
Net Debt-219.04M USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.00
Current Ratio8.13
Quick Ratio7.80
Book Value/Sh2.54 USD
Cash/Share2.74 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.417 USD
Upside (mean)+88.0%
Target Range7.000 USD – 11.25 USD
7.000+88.0% to mean11.25
# Analysts3
Ownership
Shares Out.80.20M
Float60.34M
Insiders13.37%
Institutions79.18%
Short Interest
Short Ratio32.6d
Short % Float12.26%
Short % Out.9.51%
Shares Short7.63M
Short (prev mo.)7.67M
Technical
SMA 505.214 (-3.9%)
SMA 2004.827 (+3.8%)
Beta0.39
S&P 52W Chg16.45%
Avg Vol (30d)278.53K
Avg Vol (10d)276.79K
Technical Indicators
RSI (14)41.5
MACD-0.0463
MACD Signal-0.0020
MACD Hist.-0.0442
BB Upper5.593 USD
BB Middle5.252 USD
BB Lower4.911 USD
BB Width13.00%
ATR (14)0.2221 USD
Vol Ratio (20d)0.85x